X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES WOCKHARDT LTD. ALKEM LABORATORIES/
WOCKHARDT LTD.
 
P/E (TTM) x - -18.4 - View Chart
P/BV x 7.7 3.0 254.2% View Chart
Dividend Yield % 0.6 1.1 51.7%  

Financials

 ALKEM LABORATORIES   WOCKHARDT LTD.
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
WOCKHARDT LTD.
Mar-17
ALKEM LABORATORIES/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1,5891,129 140.7%   
Low Rs1,232627 196.5%   
Sales per share (Unadj.) Rs417.5363.1 115.0%  
Earnings per share (Unadj.) Rs56.3-20.4 -275.3%  
Cash flow per share (Unadj.) Rs64.7-7.0 -927.7%  
Dividends per share (Unadj.) Rs12.7010.00 127.0%  
Dividend yield (eoy) %0.91.1 79.1%  
Book value per share (Unadj.) Rs292.9301.8 97.1%  
Shares outstanding (eoy) m119.57110.55 108.2%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x3.42.4 139.7%   
Avg P/E ratio x25.1-42.9 -58.3%  
P/CF ratio (eoy) x21.8-125.9 -17.3%  
Price / Book Value ratio x4.82.9 165.5%  
Dividend payout %22.6-48.9 -46.1%   
Avg Mkt Cap Rs m168,65397,063 173.8%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m9,1719,665 94.9%   
Avg. sales/employee Rs ThNM5,931.8-  
Avg. wages/employee Rs ThNM1,428.1-  
Avg. net profit/employee Rs ThNM-334.0-  
INCOME DATA
Net Sales Rs m49,91540,146 124.3%  
Other income Rs m1,6451,143 144.0%   
Total revenues Rs m51,56141,289 124.9%   
Gross profit Rs m8,482128 6,626.8%  
Depreciation Rs m1,0061,489 67.5%   
Interest Rs m6712,253 29.8%   
Profit before tax Rs m8,451-2,472 -341.9%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606-211 -760.8%   
Profit after tax Rs m6,731-2,260 -297.8%  
Gross profit margin %17.00.3 5,329.8%  
Effective tax rate %19.08.5 222.5%   
Net profit margin %13.5-5.6 -239.5%  
BALANCE SHEET DATA
Current assets Rs m27,06246,160 58.6%   
Current liabilities Rs m15,32419,258 79.6%   
Net working cap to sales %23.567.0 35.1%  
Current ratio x1.82.4 73.7%  
Inventory Days Days67101 66.0%  
Debtors Days Days4194 43.9%  
Net fixed assets Rs m12,61040,165 31.4%   
Share capital Rs m239553 43.3%   
"Free" reserves Rs m34,49032,814 105.1%   
Net worth Rs m35,02733,367 105.0%   
Long term debt Rs m1,21231,903 3.8%   
Total assets Rs m54,38789,687 60.6%  
Interest coverage x13.6-0.1 -14,004.4%   
Debt to equity ratio x01.0 3.6%  
Sales to assets ratio x0.90.4 205.0%   
Return on assets %13.60 -158,519.6%  
Return on equity %19.2-6.8 -283.7%  
Return on capital %24.9-0.3 -7,415.1%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,5639,121 72.0%   
Fx outflow Rs m3,0122,133 141.2%   
Net fx Rs m3,5526,988 50.8%   
CASH FLOW
From Operations Rs m7,259-2,695 -269.4%  
From Investments Rs m1,864-6,863 -27.2%  
From Financial Activity Rs m-9,27312,545 -73.9%  
Net Cashflow Rs m-1503,010 -5.0%  

Share Holding

Indian Promoters % 66.9 74.5 89.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 2.3 1,439.1%  
FIIs % 0.0 7.7 -  
ADR/GDR % 0.0 0.1 -  
Free float % 0.0 15.4 -  
Shareholders   68,381 67,757 100.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ELDER PHARMA  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 18, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - DISHMAN PHARMA COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS